BioHarvest Sciences Reports Q3 Earnings Miss and Lowers FY2026 Revenue Guidance
BioHarvest Sciences (BHST) reported third-quarter financial results that fell short of market expectations. The company posted a GAAP EPS of -$0.15, missing by $0.01, while revenue reached $7.9 million, missing consensus estimates by $1.41 million. Profitability metrics also showed significant year-over-year declines, with gross margins dropping to 54% from 61% and operating losses widening to $3 million. Looking ahead, the company issued FY2026 revenue guidance of $32 million to $33.5 million, which sits below the consensus estimate of $37.42 million. The outlook includes a projected adjusted EBITDA loss between $5.5 million and $7.5 million. Despite these headwinds, the company provided specific segment guidance for its VINIA direct-to-consumer business and CDMO operations.
Topics: earnings miss gross margin decline operating loss revenue guidance